BridgeBio Pharma Inc (BBIO) Insider Trading

Total insider buys:
  • $127,912,608.53
Total insider sells:
  • $1,261,280,670.23
Most recent insider trade:
  • Aug. 21, 2025
Most active insider trader:
  • Neil Kumar
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 21, 2025CFO42,237$49.48Sell$2,089,886.76
Aug. 20, 2025CEO26,156$48.82Sell$1,276,935.92
Aug. 18, 2025CFO17,353$50.23Sell$871,641.19
Aug. 11, 2025Director50,000$48.00Sell$2,400,000.00
Aug. 8, 2025Director250,000$46.05Sell$11,512,500.00
Aug. 7, 2025CAO1,000$45.44Sell$45,440.00
Aug. 7, 2025CEO40,000$45.45Sell$1,818,000.00
Aug. 5, 2025Director17,167$49.00Sell$841,183.00
July 1, 2025CEO40,000$42.54Sell$1,701,600.00
June 27, 2025Major Shareholder3,500,000$44.00Sell$154,000,000.00
June 26, 2025Director2,418$44.05Sell$106,512.90
June 24, 2025Director100,000$44.23Sell$4,423,000.00
June 10, 2025Director4,292$40.00Sell$171,680.00
May 20, 2025CEO75,000$33.40Sell$2,505,000.00
May 19, 2025CEO26,156$33.33Sell$871,779.48
May 12, 2025Major Shareholder6,000,000$34.20Sell$205,200,000.00
May 2, 2025Director100,000$38.50Sell$3,850,000.00
May 2, 2025CAO1,026$38.51Sell$39,511.26
April 22, 2025CEO75,000$34.11Sell$2,558,250.00
April 14, 2025Director10,000$35.00Sell$350,000.00
April 1, 2025Director30,000$34.05Sell$1,021,500.00
March 25, 2025CEO75,000$36.87Sell$2,765,250.00
March 5, 2025Major Shareholder6,000,000$32.96Sell$197,760,000.00
Feb. 25, 2025CFO8,500$33.19Sell$282,115.00
Feb. 25, 2025CEO75,000$33.57Sell$2,517,750.00
Feb. 19, 2025CEO31,543$36.14Sell$1,139,964.02
Feb. 19, 2025CFO4,148$36.16Sell$149,991.68
Jan. 31, 2025Major Shareholder3,065,616$34.90Sell$106,989,998.40
Jan. 28, 2025CEO326,932$36.29Sell$11,864,362.28
Jan. 28, 2025CFO68,000$36.29Sell$2,467,720.00
Nov. 19, 2024CFO4,156$22.41Sell$93,135.96
Nov. 19, 2024CEO27,389$22.41Sell$613,787.49
Sept. 13, 2024Major Shareholder5,800,000$25.75Sell$149,350,000.00
Aug. 19, 2024CEO27,389$24.69Sell$676,234.41
Aug. 19, 2024CFO4,155$24.69Sell$102,586.95
June 3, 2024Director1,000$28.84Sell$28,840.00
March 1, 2024Director2,500$34.00Sell$85,000.00
Jan. 16, 2024Director2,915$37.97Sell$110,682.55
Dec. 26, 2023Director100,000$42.06Sell$4,206,000.00
Dec. 18, 2023Director2,000$40.00Sell$80,000.00
Aug. 17, 2023CEO51,552$28.59Sell$1,473,871.68
Aug. 17, 2023CFO22,683$28.59Sell$648,506.97
July 18, 2023Major Shareholder1,500,000$35.00Sell$52,500,000.00
May 17, 2023CEO51,552$14.01Sell$722,243.52
May 17, 2023CFO24,424$14.01Sell$342,180.24
April 5, 2023CFO55,500$15.45Sell$857,475.00
April 5, 2023CEO120,000$15.46Sell$1,855,200.00
March 3, 2023CFO62,692$10.96Sell$687,104.32
March 3, 2023CEO120,000$10.96Sell$1,315,200.00
Feb. 17, 2023CEO44,798$12.70Sell$568,934.60
First«1 of 3»Last
  • Insiders are both buying and selling BridgeBio Pharma Inc stock.

  • The insider traders at BridgeBio Pharma Inc are: Neil Kumar, Brian C Stephenson, Cameron Turtle, Genetic Disorder L.P. Kkr, Michael Thomas Henderson, Charles J Homcy, Randal W Scott, Frank Mccormick, Global Investors Lp Viking, Andrea Ellis, Charles J. Homcy, Hannah Valantine, Ronald J Daniels, Thomas Trimarchi, Douglas A Dachille, Maricel Apuli, Richard H Scheller, Andrew Lo, and Brian C. Stephenson

  • The most active insider trader at BridgeBio Pharma Inc is Neil Kumar with 28 trades.

  • Genetic Disorder L.P. Kkr has sold the most BridgeBio Pharma Inc stock with a total value of $1,045,923,249.10.

  • Global Investors Lp Viking has bought the most BridgeBio Pharma Inc stock with a total value of $160,000,600.00.

  • The most recent insider trade for BridgeBio Pharma Inc was on Aug. 21, 2025.

  • The single biggest insider buy for BridgeBio Pharma Inc was from Global Investors Lp Viking with a total value of $80,000,300.00 on June 27, 2019.

  • The single biggest insider sell for BridgeBio Pharma Inc was from Genetic Disorder L.P. Kkr with a total value of $208,621,500.00 on Feb. 17, 2021.